Anti-Restenosis After AMI by Erythropoietin

NCT00423020 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: Erythropoietin

Sponsor

Kyoto Prefectural University of Medicine